InvestorsHub Logo
Followers 7
Posts 299
Boards Moderated 0
Alias Born 01/07/2010

Re: None

Friday, 07/26/2019 10:29:44 PM

Friday, July 26, 2019 10:29:44 PM

Post# of 461360
Did anyone notice a new study involving AVXL on Clinical Trials?

"Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects"

ClinicalTrials.gov Identifier: NCT04025502 (First Posted: July 19, 2019)

Sponsor:
ERP Biomarker Qualification Consortium

Collaborators:
COGNISION
Cadent Therapeutics
Alkermes, Inc.
Anavex Life Sciences Corp.
Merck Sharp & Dohme Corp.
Takeda
Sage Therapeutics
H. Lundbeck A/S

We are among the HEAVY HITTERS now!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News